Ray Dalio's position in Abbvie is currently worth $127M. That's 0.50% of their equity portfolio (46th largest holding). The first Abbvie trade was made in Q4 2020. Since then Ray Dalio bought shares ten more times and sold shares on eight occasions. The stake costed the investor $96.6M, netting the investor a gain of 32% so far.